127 related articles for article (PubMed ID: 35653620)
1. PLGA-based microspheres containing ropivacaine and betamethasone for sciatic nerve block in mice.
Wang C; Yang J; Chang W
Pharm Dev Technol; 2022 Jun; 27(5):503-510. PubMed ID: 35653620
[TBL] [Abstract][Full Text] [Related]
2. Preparation of novel ropivacaine hydrochloride-loaded PLGA microspheres based on post-loading mode and efficacy evaluation.
Wen K; Na X; Yuan M; Bazybek N; Li X; Wei Y; Ma G
Colloids Surf B Biointerfaces; 2022 Feb; 210():112215. PubMed ID: 34839050
[TBL] [Abstract][Full Text] [Related]
3. Development and Evaluation of Ropivacaine Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres with Low Burst Release.
Zhao X; Gao Y; Tang X; Lei W; Yang Y; Yu F; Liu Y; Yang M; Wang Y; Gong W; Li Z; Gao C; Mei X
Curr Drug Deliv; 2019; 16(6):490-499. PubMed ID: 31132975
[TBL] [Abstract][Full Text] [Related]
4. Preparation of poly(lactide-co-glycolide) microspheres and evaluation of pharmacokinetics and tissue distribution of BDMC-PLGA-MS in rats.
Li G; Yao L; Li J; Qin X; Qiu Z; Chen W
Asian J Pharm Sci; 2018 Jan; 13(1):82-90. PubMed ID: 32104381
[TBL] [Abstract][Full Text] [Related]
5. Preparation of novel biodegradable ropivacaine microspheres and evaluation of their efficacy in sciatic nerve block in mice.
Ni Q; Chen W; Tong L; Cao J; Ji C
Drug Des Devel Ther; 2016; 10():2499-506. PubMed ID: 27536071
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and pharmacodynamics of poly (lactide-co-glycolide) microspheres containing ropivacaine and dexamethasone for sciatic nerve block in mice].
Yu RH; Chen ZQ; Chen H; Fu WJ; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):502-5. PubMed ID: 20335120
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization and in vitro/in vivo Evaluation of Lovastatin-Loaded PLGA Microspheres by Local Administration for Femoral Head Necrosis.
Sun Y; Long D
Drug Des Devel Ther; 2021; 15():601-610. PubMed ID: 33623369
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and Release Properties of
Chen YZ; Liu RJ; Yang L; Li MY; Suolangsizhu ; Li WY; Wang BN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Sep; 52(5):794-798. PubMed ID: 34622595
[TBL] [Abstract][Full Text] [Related]
10. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
11. Localized delivery of brain-derived neurotrophic factor from PLGA microspheres promotes peripheral nerve regeneration in rats.
Shi ZL; Fan ZY; Zhang H; Li ST; Yuan H; Tong JH
J Orthop Surg Res; 2022 Mar; 17(1):172. PubMed ID: 35303915
[TBL] [Abstract][Full Text] [Related]
12. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
13. Development and Characterization of Olanzapine Loaded Poly(lactide-coglycolide) Microspheres for Depot Injection: In vitro and In vivo Release Profiles.
Pervaiz F; Ahmad M; Li L; Murtaza G
Curr Drug Deliv; 2019; 16(4):375-383. PubMed ID: 30588882
[TBL] [Abstract][Full Text] [Related]
14. Engineered PLGA microspheres for extended release of brexpiprazole:
Wu B; Wu L; He Y; Yin Z; Deng L
Drug Dev Ind Pharm; 2021 Jun; 47(6):1001-1010. PubMed ID: 34032181
[TBL] [Abstract][Full Text] [Related]
15. Novel insights on the encapsulation mechanism of PLGA terminal groups on ropivacaine.
Li X; Wei Y; Wen K; Han Q; Ogino K; Ma G
Eur J Pharm Biopharm; 2021 Mar; 160():143-151. PubMed ID: 33524537
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection.
Park CW; Lee HJ; Oh DW; Kang JH; Han CS; Kim DW
Drug Des Devel Ther; 2018; 12():711-719. PubMed ID: 29670329
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics and pharmacodynamics of lidocaine- loaded biodegradable poly(lactic-co-glycolic acid) microspheres.
Liu J; Lv X
Int J Mol Sci; 2014 Sep; 15(10):17469-77. PubMed ID: 25268618
[TBL] [Abstract][Full Text] [Related]
19. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Fu X; Ping Q; Gao Y
J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
